M FR 2.5 (Frovatriptan succinate 2.5 mg (base))
Pill imprint M FR 2.5 has been identified as Frovatriptan succinate 2.5 mg (base).
Frovatriptan is used in the treatment of migraine and belongs to the drug class antimigraine agents. Risk cannot be ruled out during pregnancy. Frovatriptan 2.5 mg (base) is not a controlled substance under the Controlled Substance Act (CSA).
More about frovatriptan
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 38 Reviews – Add your own review/rating
- Drug class: antimigraine agents
Other brands: Frova
- Frovatriptan Succinate (AHFS Monograph)
- Frovatriptan Succinate Tablets (FDA)
- Frovatriptan (Wolters Kluwer)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.